Epica International Appoints Daniel Naimey to VP of Market and Business Development

Press Release (ePRNews.com) - SAN CLEMENTE, Calif. - Dec 20, 2017 - On Dec. 4, 2017, Daniel Naimey joined Epica International Inc. as Vice President of Market and Business Development. Mr. Naimey reports to CEO, Frank D’Amelio, and works from Epica International’s San Clemente, California headquarters.

Mr. Naimey will focus initially on the global expansion of Epica’s CT technology into the human market and the company’s industrial robot strategy. This will be followed by analytical support for the group’s Human CT and Robotics program.

Mr. Naimey’s prior experience includes management positions at Covidien, where he led endo-mechanical business development/M&A and held a GM role in the company’s global sports medicine business. He was also the strategic business development lead for the Surgical Solutions’ Advanced MIS team, driving new product development and revenue growth from the company’s 2007 IPO to its acquisition by Medtronic in 2015. Daniel has an extensive knowledge of CT and surgical robotics, facilitated the licensing and acquisition of numerous robotic patents, and initiated Covidien’s move into non-invasive surgery systems for lung cancer diagnostics through the $350M acquisition of SuperDimension.

Daniel initiated and developed subsequent acquisitions including Power Medical, Given Imaging, and Pnavel Systems. He possesses extensive international experience and has launched and branded medical devices globally. Notably, Daniel also participated in the development of Covidien’s China Strategy including M&A opportunity assessment, market assessment and the decision to establish a China-based R&D center.

Daniel earned a bachelor’s degree in international business on an academic scholarship and completed professional coursework in global marketing and entrepreneurship at Yale University.

Business Info :
Facilitated Growth LLC

You may also like this  

CATEGORIES : Uncategorized
DISCLAIMER : If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/services/business mentioned and hereby disclaims any content contained in this press release.

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login